![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Alibaba
BABA
Cisco
CSCO
Qualcomm
QCOM
Amazon
AMZN
Apple
AAPL
US Stock MarketDetailed Quotes
PFE Pfizer
- 26.740
- +0.090+0.34%
Close Feb 25 16:00 ET
- 26.670
- -0.070-0.26%
Pre 04:50 ET
151.54BMarket Cap18.96P/E (TTM)
27.030High26.540Low43.56MVolume26.720Open26.650Pre Close1.17BTurnover0.77%Turnover Ratio18.96P/E (Static)5.67BShares30.55252wk High1.64P/B151.31BFloat Cap23.71352wk Low1.68Dividend TTM5.66BShs Float53.002Historical High6.28%Div YieldTTM1.84%Amplitude5.306Historical Low26.794Avg Price1Lot Size
Pfizer Stock Forum
Sign in to post a comment
2
1
$Pfizer (PFE.US)$
Chart looks good. Next resistance is 26.92. Once it breaks the resistance, next hit point will be 27.01.
Chart looks good. Next resistance is 26.92. Once it breaks the resistance, next hit point will be 27.01.
Get onboard before its too late. I believe it will go nearly 30 in 3months.
4
$Summit Therapeutics (SMMT.US)$ $Pfizer (PFE.US)$
Can This Summit-Pfizer Cancer Drug Combo Revolutionize Solid Tumor Treatment?
Can This Summit-Pfizer Cancer Drug Combo Revolutionize Solid Tumor Treatment?
1
$Pfizer (PFE.US)$
A nice double bottom pattern in the chart. The stock is trading above 5 EMA, 10 EMA, 20 EMA, 60 EMA and 120 EMA. The trend is up. Once it breaks above $27, the trend is confirmed bullish.
A nice double bottom pattern in the chart. The stock is trading above 5 EMA, 10 EMA, 20 EMA, 60 EMA and 120 EMA. The trend is up. Once it breaks above $27, the trend is confirmed bullish.
3
4
$Pfizer (PFE.US)$
Chart looks good. Next resistance is 26.47. Once it breaks the resistance, next hit point will be 26.69.
Chart looks good. Next resistance is 26.47. Once it breaks the resistance, next hit point will be 26.69.
$Pfizer (PFE.US)$
Summit Therapeutics and Pfizer will work together to study Summit's promising cancer drug candidate ivonescimab and Pfizer's antibody drug conjugates, or ADCs, in solid tumors.
Summit on Monday said the companies plan to evaluate ivonescimab in combination with several Pfizer ADCs across multiple solid tumor settings to determine the safety profile and potential anti-tumor activity of the combinations.
Miami biopharmaceutical company Summit said it will provide ivonescimab for...
Summit Therapeutics and Pfizer will work together to study Summit's promising cancer drug candidate ivonescimab and Pfizer's antibody drug conjugates, or ADCs, in solid tumors.
Summit on Monday said the companies plan to evaluate ivonescimab in combination with several Pfizer ADCs across multiple solid tumor settings to determine the safety profile and potential anti-tumor activity of the combinations.
Miami biopharmaceutical company Summit said it will provide ivonescimab for...
1
1
$Summit Therapeutics (SMMT.US)$ $Pfizer (PFE.US)$
Can This New Summit-Pfizer Cancer Drug Combo Transform Solid Tumor Treatment?
Can This New Summit-Pfizer Cancer Drug Combo Transform Solid Tumor Treatment?
No comment yet
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Deep Sea : Going for 29 soon.
Marquezs OP :
A man brother 
Deep Sea Marquezs OP :![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")